--Mr. Grissinger brings more than four decades of leadership experience in pharmaceutical business development and strategic transactions-- REDWOOD CITY, Calif. & BOSTON, April 17, 2025--(BUSINESS ...

April 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointments of biotech industry veterans Kim Cobleigh Drapkin, CPA, and Bo Cumbo to its Board of Directors.

WELLESLEY HILLS, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointments of biotech industry veterans Kim Cobleigh Drapkin, CPA, and Bo Cumbo to its ...

“We are honored to welcome Michael to our Board of Directors,” said Chen Schor, President and Chief Executive Officer of Adicet Bio. “His extensive operational and business development ...

Dr. Heyman takes the role of Chair of the Board of Directors after serving as a senior ... he served as Chair of Vividion Therapeutics, Rayze Bio and Amunix Pharma. Previously, Heyman was the ...

Climb Bio, Inc., a pharmaceutical company specializing in preparations with a market capitalization of $82.32 million, announced the expansion of its board of directors and the departure of two ...

This Merger follows Longevity’s acquisition of Elevai Skincare in January 2025. The combination with 20/20 advances the Company’s March 10, 2025 announcement of its new strategy to build a footprint ...